Search

Presents a study on how to assess whether patients with CD4+ cell counts less than 200, have a decreased survival after an occurrence of any AIDS-defining event. Number of HIV-infected patients who participated in the study; What was used in the study to understand relationships between baseline variables; Effect of baseline variables and intermediate events on the risk of dying of patients included in the placebo arm of the ANRS 005-ACTG 154 trial.